ENTITY
Green Cross Cell

Green Cross Cell (031390 KS)

11
Analysis
Health Care • South Korea
Green Cross Cell Corp is a biotechnology company. The Company develops and commercializes bio-products for immunity cell therapy, and operates autologous lymphocyte, cord blood, and tumor cell bank. Green Cross also tests extreme drug resistance assay (EDR).
more
bearish•Cross Asset Strategy
•26 Nov 2020 00:35

KOSDAQ150 and KRX300 Indices Rebalances (Overlapping Additions & Deletions)

We highlight the KOSDAQ150 and KRX300 indices rebalances. There are some interesting new names, especially among those that are over lapping in...

Logo
453 Views
Share
•08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Logo
4.2k Views
Share
•07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.6k Views
Share
bullish•M2N Co.,Ltd
•02 Nov 2021 13:43

KOSDAQ150 Index Rebalance Preview: 15 Potential Changes and Large Turnover

At the end of the review period, we see 15 potential changes for the KOSDAQ150 index. Most of the changes are high probability. The adds could...

Logo
888 Views
Share
bearish•Eubiologics
•20 Oct 2021 08:25

KOSDAQ150 Index Rebalance: Green Cross Merger & EuBiologics Addition

EuBiologics will be added to the KOSDAQ150 Index at the close on 27 Oct due to the Green Cross merger. We would look to be long EuBio for the next...

Logo
599 Views
Share
x